Rossari Biotech schedules Board meeting on October 24 to approve Q2 results
Rossari Biotech Ltd. announced on Saturday that it has scheduled its Board Meeting on October 24 to approve its Q2 FY2021 result.
The Mumbai based company stated in its BSE regulatory filing. “Pursuant to the Regulation 30 and 4 7 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are enclosing herewith Notice of Board Meeting scheduled on October 24, 2020 published in Financial Express (English Daily) and Loksatta (Marathi Daily) dated October 17, 2020.”
“Notice is hereby given pursuant to Regulation 29 read with Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, that a meeting of the Board of Directors of the Company is scheduled on Saturday, October 24, 2020, inter afia, to consider, approve and take on record the Un-audited Financial Results (Standalone and Consolidated) for the quarter ended Septmber 30, 2020.” (Financial Express)
It’s time to burst the bubble! The bubble of myth, ‘#disinfectants made of harsh chemicals have strong properties.’ And bring into light effective and sustainable #solutions of #green cleaning that are developed with #efficient scientific strategies.
More: https://t.co/38gP8Wlqs2 pic.twitter.com/18fy7DPBvV
— Rossari Biotech (@RossariB) October 16, 2020